From: Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study
Cardiovascular manifestations previously treated by surgery | Number of patients affected |
mitral valve prolapse | 3 |
tricuspid valve prolapse | 1 |
aortic dissection stanford A | 1 |
aortic dissection stanford B | 2 |
aortic regurgitation | 7 |
aortic aneurysma | 9 |
mitral regurgitation | 2 |
patent foramen ovale | 1 |
pulmonary artery dilatation | 1 |
Cardiovascular manifestations not yet treated by surgery | Number of patients affected |
mild mitral valve prolapse | 1 |
ascending aorta <45 mm | 2 |
Corresponding medication | Number of patients treated with |
angiotensin II receptor antagonist | 13 |
beta 1 receptor blocker | 8 |
aspirin | 4 |
phenprocoumon | 4 |
diuretics | 1 |
calcium channel blocker | 2 |
simvastatine | 2 |
none (refused by patient) | 2 |
Previous cardiovascular surgery | Number of patients treated with |
david procedure | 6 |
aortic valve replacement | 4 |
mitral valve replacement | 1 |
aortic prothesis | 5 |
aortic valve reconstruction | 2 |
mitral valve reconstruction | 2 |
patent foramen ovale closure | 1 |
Current NYHA functional classification | Number of patients |
NYHA I | 12 |
NYHA II | 6 |